For parents whose children are undergoing growth hormone therapy, the focus might be on height and physical development, but ...

Mr. Cho, 41, a public official, has been administering growth hormone injections to his first son, 10, a fourth-grade elementary school student, since March of this year. Six days a week, Mr. Cho ...

The U.S. hormone therapy market is expanding due to rising healthcare costs, an aging population, and patient-centered care trends favoring home-based treatments. Opportunities include user-friendly ...

Growth hormone receptor (GHR) signaling in bladder cancer is associated with advanced tumor stages and poor survival outcomes. High GHR expression in tumors up-regulates genes involved in drug ...

More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the ...

Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA®– Q3 2025 operating profit of €11.0 million– TransCon® ...

Elon Musk and Joe Rogan suggested that Jeff Bezos’ muscly physique might be partially due to testosterone injections. The 61-year-old Amazon founder and Washington Post owner is “definitely doing some ...

Peptide stacking has potential in regenerative and longevity medicine, but using unregulated or poorly studied peptides is ...

A child's healthy growth is a complex interplay of genetics, hormones and nutrition. Experts emphasize that factors like ...

Peptides are an important class of drugs. Almost 100 are approved as medicines, including insulin, human growth hormone and ...

Ascendis Pharma’s consensus analyst price target has recently increased from $245.61 to $258.77 per share. This reflects a renewed sense of optimism as Yorvipath’s uptake accelerates and real-world ...